CRS in a Nutshell

A world’s leading full service early phase CRO

CRS research

With three research units in the largest metropolitan regions of Germany and a total capacity of over 160 in-house beds, CRS offers its clients innovative concepts and intelligent solutions in the field of early clinical development – from First-in-Human, Proof-of-Concept in patients.

CRS Research Mannheim
With our outstanding expertise and vast experience, CRS is the ideal candidate for biopharmaceutical companies – regardless of their size – to establish a strategic or tactical project-related outsourcing partnership.
CRS – Partner with a remarkable track record
CRS Kiel
CRS ist eines der führenden klinischen Forschungsinstitute Europas und bietet Ihnen diverse Möglichkeiten, aktiv an der klinischen Entwicklung von Arzneimitteln und medizinischen Produkten unserer Kunden mitzuarbeiten.

Especially in the fields of metabolic and cardiovascular disorders and woman’s health we consistently demonstrate an extraordinary expertise. Also particularly noteworthy is our outstanding performance in conducting clinical trials in renal and hepatic impaired patients.

Overall, in the above listed fields but in other therapeutic areas too, CRS can show a remarkable track record. Taking a drug to market is a long and exciting way on which one is often confronted with unexpected obstacles and challenges. Engaging early with experts is therefore of inestimable value.

We at CRS – with a wealth of experience gathered over more than 40 years – provide all our knowledge to best design your early phase drug development strategy.